tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Oka K et al. A case of tacrolimus nephrotoxicity appearing in a second renal transplantation patient. 2001 Clin Transplant pmid:11791792
Iguchi S et al. Intratubular calcification in a post-renal transplanted patient with secondary hyperparathyroidism. 2001 Clin Transplant pmid:11791796
D'Antiga L et al. Late cellular rejection in paediatric liver transplantation: aetiology and outcome. 2002 Transplantation pmid:11792983
Butani L et al. Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. 2002 Transplantation pmid:11793001
Boots JM et al. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients. 2001 Transpl. Int. pmid:11793034
Chang RW et al. European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients. 2001 Transpl. Int. pmid:11793035
Lo A et al. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. 2001 Transpl. Int. pmid:11793037
Venkiteswaran K et al. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients. 2001 Transpl. Int. pmid:11793038
Hymes LC and Warshaw BL Tacrolimus rescue therapy for children with acute renal transplant rejection. 2001 Pediatr. Nephrol. pmid:11793086
Tanaka K et al. Effects of immunophilin ligands on hydrogen peroxide-induced apoptosis in C6 glioma cells. 2002 Synapse pmid:11793428
Tacrolimus. 2001 Am J Health Syst Pharm pmid:11794952
Jain A et al. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. 2002 Liver Transpl. pmid:11799484
Turvey SE Atopic diseases of childhood. 2001 Curr. Opin. Pediatr. pmid:11801897
Itagaki F et al. Effect of ascites on tacrolimus disposition in a liver transplant recipient. 2001 Ther Drug Monit pmid:11802097
Zylber-Katz E and Granot E Abrupt increase of tacrolimus blood levels during an episode of Shigella infection in a child after liver transplantation. 2001 Ther Drug Monit pmid:11802098
Espino G et al. Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD. 2001 Bone Marrow Transplant. pmid:11803349
Girman P et al. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. 2001 Ann. Transplant. pmid:11803619
Olyaei AJ et al. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. 2001 Curr Opin Crit Care pmid:11805539
Holt DW et al. International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring. 2002 Ther Drug Monit pmid:11805724
Nghiem P et al. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. 2002 J. Am. Acad. Dermatol. pmid:11807435
Suga Y et al. Topical tacrolimus for chronic actinic dermatitis. 2002 J. Am. Acad. Dermatol. pmid:11807453
Yoshimasu T et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. 2002 Jan-Feb Eur J Dermatol pmid:11809595
Li TK et al. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin. 2002 J. Cell. Biochem. pmid:11813252
Pascual MA et al. Progress in understanding humoral rejection in kidney transplantation: implications for patient management. 2001 Jul-Aug Nefrologia pmid:11816504
Peces R et al. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors]. 2001 Jul-Aug Nefrologia pmid:11816517
Cho ML et al. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. 2002 Arthritis Rheum. pmid:11817607
Sugden PH Signalling pathways in cardiac myocyte hypertrophy. 2001 Ann. Med. pmid:11817656
Kotanko P et al. Rhabdomyolysis and acute renal graft impairment in a patient treated with simvastatin, tacrolimus, and fusidic acid. 2002 Nephron pmid:11818715
Iyer KR et al. Late graft loss and long-term outcome after isolated intestinal transplantation in children. 2002 J. Pediatr. Surg. pmid:11819189
Bennett PC et al. Cyclosporin A, FK506 and rapamycin produce multiple, temporally distinct, effects on memory following single-trial, passive avoidance training in the chick. 2002 Brain Res. pmid:11821011
Homma M et al. Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. 2002 Transplantation pmid:11821750
Hopt UT [New developments in immunosuppressive therapy]. 2001 Kongressbd Dtsch Ges Chir Kongr pmid:11824327
Ponseti JM et al. [Tacrolimus (FK506) in the treatment of prednisone-resistant myasthenia gravis. Preliminary results of 20 cases]. 2002 Med Clin (Barc) pmid:11825555
Yoshida EM Post-liver transplantation immunosuppression: the song does not remain the same. 2002 Can. J. Gastroenterol. pmid:11826341
Zhang W Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. 2002 Cardiovasc. Res. pmid:11827679
Mazzone PJ et al. The humoral immune response to influenza vaccination in lung transplant patients. 2001 Eur. Respir. J. pmid:11829104
Okabe H et al. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction. 2002 J. Pharm. Pharmacol. pmid:11829131
MacDonald A Improving tolerability of immunosuppressive regimens. 2001 Transplantation pmid:11833142
Kato Y et al. Effect of epidermal growth factor on intestinal adaptation after allogeneic small bowel transplantation in rats. 2002 Life Sci. pmid:11833743
Van Leent EJ et al. Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis. 2002 Dermatology (Basel) pmid:11834853
Lü L et al. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats]. 1999 Zhonghua Yan Ke Za Zhi pmid:11835769
Garcia M et al. Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes. 2002 Dig. Dis. Sci. pmid:11837721
Kruszka SJ and Gherman RB Successful pregnancy outcome in a lung transplant recipient with tacrolimus immunosuppression. A case report. 2002 J Reprod Med pmid:11838314
Takeda Y et al. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. 2002 Circulation pmid:11839620
Clemons PA et al. Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors. 2002 Chem. Biol. pmid:11841938
Tsoulfas G and Geller DA NF-kappaB in transplantation: friend or foe? 2001 Transpl Infect Dis pmid:11844153
Brenner BC et al. Mechanisms of L-selectin-induced activation of the nuclear factor of activated T lymphocytes (NFAT). 2002 Biochem. Biophys. Res. Commun. pmid:11846396
Cruz MC et al. Calcineurin is essential for survival during membrane stress in Candida albicans. 2002 EMBO J. pmid:11847103
Tada H et al. Effects of thymic hormone on reactive oxygen species-scavengers and renal function in tacrolimus-induced nephrotoxicity. 2002 Life Sci. pmid:11848304
Baboolal K et al. Molecular and structural consequences of early renal allograft injury. 2002 Kidney Int. pmid:11849412
Fauvel H et al. Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. 2002 Am. J. Respir. Crit. Care Med. pmid:11850335
Suehiro A et al. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation. 2002 Bone Marrow Transplant. pmid:11850703
O'Connell PJ et al. Identification of functional type 1 ryanodine receptors in mouse dendritic cells. 2002 FEBS Lett. pmid:11852053
Wu Y and Anderson ME Reduced repolarization reserve in ventricular myocytes from female mice. 2002 Cardiovasc. Res. pmid:11861046
Keshavarz R et al. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant. 2002 Pediatr Emerg Care pmid:11862133
Kato T et al. Intestinal and multivisceral transplantation. 2002 World J Surg pmid:11865353
Parasrampuria DA et al. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. 2002 J Clin Pharmacol pmid:11865967
Okoshi Y et al. [A case of FK 506-induced leukoencephalopathy]. 2002 No To Shinkei pmid:11868353
Tanaka K et al. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. 2002 Neurosci. Lett. pmid:11872253
Lawrence MC et al. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. 2002 Diabetes pmid:11872668
Choi SH et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. 2002 Scand. J. Infect. Dis. pmid:11874173
Kosch M et al. Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients. 2002 J. Hypertens. pmid:11875318
Dunn SE et al. Calcineurin and skeletal muscle growth. 2002 Nat. Cell Biol. pmid:11875443
Sarahrudi K et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. 2002 Transpl. Int. pmid:11875609
Lytton SD et al. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. 2002 Clin. Exp. Immunol. pmid:11876753
Lü L and Zhang W [Immunopathologic studies on the effects of immunosuppressant FK 506 on penetrating keratoplasty rejection model in rat]. 1998 Zhonghua Yan Ke Za Zhi pmid:11877144
Israni A et al. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. 2002 Am. J. Kidney Dis. pmid:11877596
Cron RQ HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed? 2001 DNA Cell Biol. pmid:11879569
Toyonaga T et al. Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. 2002 Diabetes Res. Clin. Pract. pmid:11879716
Pascual J [Toward an evidence-based immunosuppression]. 2001 Nefrologia pmid:11881421
McCluskey A et al. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. 2002 J. Med. Chem. pmid:11881984
Lanzetta M et al. Hand transplantation: ethics, immunosuppression and indications. 2001 J Hand Surg Br pmid:11884098
Merle M Some aspects of hand transplantation. 2001 J Hand Surg Br pmid:11884103
Barone GW et al. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. 2002 JOP pmid:11884766
Paty BW et al. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. 2002 Transplantation pmid:11884930
Präst I et al. Nerve cells in transplanted pancreatic islets: no effects of cyclosporin or tacrolimus on immediate neuronal survival. 2001 Ups. J. Med. Sci. pmid:11888070
del Mar Fernández De Gatta M et al. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. 2002 Clin Pharmacokinet pmid:11888332
Margreiter R Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. 2002 Lancet pmid:11888584
Stempfle HU et al. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. 2002 Transplantation pmid:11889427
Panz VR et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1. 2002 Transplantation pmid:11889436
Nishigaki F et al. FK506 induces chondrogenic differentiation of clonal mouse embryonic carcinoma cells, ATDC5. 2002 Eur. J. Pharmacol. pmid:11890899
Beltrani VS Tacrolimus ointment: advancing the treatment of atopic dermatitis. 2001 Curr Allergy Asthma Rep pmid:11892051
Tang WX et al. Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11893565
Cohen SM Current immunosuppression in liver transplantation. 2002 Mar-Apr Am J Ther pmid:11897926
Allen BR Tacrolimus ointment: its place in the therapy of atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11897982
Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11898004
Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11898005
Doi M et al. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. 2002 Circulation pmid:11901051
Vögelin E et al. Long-term viability of articular cartilage after microsurgical whole-joint transplantation and immunosuppression with rapamycin, mycophenolate mofetil, and tacrolimus. 2002 J Hand Surg Am pmid:11901390
Bos JD Topical tacrolimus and pimecrolimus are not associated with skin atrophy. 2002 Br. J. Dermatol. pmid:11903264
Fuhrer DK et al. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. 2001 Diabetes Obes Metab pmid:11903410
Ishikawa K et al. Mycobacterium tuberculosis infection of bilateral cervical lymph nodes after renal transplantation. 2001 Int. J. Urol. pmid:11903693
Sakanoue M et al. Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor activity of quinpirole, but not that of SKF82958, in male rats. 2002 Eur. J. Pharmacol. pmid:11906716
Holt S and Moore K Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. 2002 Transplantation pmid:11907407
Yang H et al. Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. 2002 Transplantation pmid:11907415
Klein IH et al. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. 2002 Transplantation pmid:11907418
Vincenti F et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. 2002 Transplantation pmid:11907427
Eichenfield LF et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. 2002 J. Am. Acad. Dermatol. pmid:11907497
Dé Tran QH et al. Tacrolimus in dermatology. 2001 Jul-Aug J Cutan Med Surg pmid:11907845
Lacour JP [Topical tacrolimus in dermatology: what can one expect?]. 2001 Ann Dermatol Venereol pmid:11908129